Skip to content
Screener

Vertex Pharmaceuticals VRTX Tax Reconciliation: Research and Other Credits

Tax Reconciliation: Research and Other Credits at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
0—
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
0—
Xylem logo
XylemXYL
0.2%0.0pp
Teledyne Technologies logo
Teledyne TechnologiesTDY
0.4%0.0pp
International Business Machines logo
International Business MachinesIBM
0—
Ford Motor Company logo
Ford Motor CompanyF
-0.7%—

Other financials

Income statement

See full
Revenue$3.3B+12.5%
Gross profit$2.8B+11.2%
Operating income$1.2B+8.3%
Net income$1.1B+6.5%
EPS (diluted)$4.31+8.0%

Balance sheet

See full
Cash & equivalents$7.9B+57.6%
Total debt$2.0B+29.5%
Total equity$20.2B+17.9%
Total assets$27.4B+14.1%

Cash flow

See full
Operating cash flow$1.4B+74.4%
CapEx$133.4M+228%
Free cash flow$1.3B+66.4%

Valuation

See full
Market cap$122.89B+24.3%
Enterprise value$117.01B+22.6%
P/E27.9×—
P/S9.8×+1.1×

Profitability

See full
Gross margin86%-0.1pp
Operating margin38%—
Net margin35%—
FCF margin30.4%+20.2pp

Returns & leverage

See full
Return on equity23.5%—
Debt / equity0.1×0.0×
Current ratio3.2×+0.7×

FAQ

What does tax reconciliation: research and other credits mean?
The aggregate impact of research and development tax credits and other related incentives on the effective tax rate. This metric quantifies the benefit of government-sponsored innovation incentives.